Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Lin

Showing results (11-20 of 287) with videos related to

Pageof 29
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2004
Does the who and how of surgery in bladder cancer matter?Paul H Lange, Daniel W Lin
Current Urology Reports|August 15, 2018
Improving the Specificity of PSA Screening with Serum and Urine MarkersJames T Kearns, Daniel W Lin
Current Opinion in Urology|June 27, 2017
Prediction models for prostate cancer outcomes: what is the state of the art in 2017?James T Kearns, Daniel W Lin
Urologic Oncology|November 23, 2005
Editorial comment on "Treatment of nonretroperitoneal residual germ cell tumor masses"Daniel W Lin, Paul H Lange
Nature Reviews. Urology|December 4, 2009
Genetics: Prostate cancer risk stratification by genotype and PSAJonathan L Wright, Daniel W Lin
JAMA Oncology|November 5, 2016
Avoiding Undertreatment of Aggressive Prostate Cancer by Early Use of ChemotherapyEvan Y Yu, Daniel W Lin
European Urology|April 15, 2020
Active Surveillance for Prostate Cancer: A 2020 VisionMatthew R Cooperberg, Daniel W Lin
Urologic Oncology|July 14, 2007
Trends in renal cancer surgery and patient provider characteristics associated with partial nephrectomy in the United StatesMichael P Porter, Daniel W Lin
JAMA Oncology|November 25, 2020
Prognostic Genomic Biomarkers in Patients With Localized Prostate Cancer: Is Rising Utilization Justified by Evidence?Daniel W Lin, Peter S Nelson
Translational Andrology and Urology|August 25, 2021
Preface to "Current and Future Topics on Prostate Cancer"Badrinath R Konety, Daniel W Lin
Pageof 29

Showing results (11-20 of 287) with videos related to

Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2004
Does the who and how of surgery in bladder cancer matter?Paul H Lange, Daniel W Lin
Current Urology Reports|August 15, 2018
Improving the Specificity of PSA Screening with Serum and Urine MarkersJames T Kearns, Daniel W Lin
Current Opinion in Urology|June 27, 2017
Prediction models for prostate cancer outcomes: what is the state of the art in 2017?James T Kearns, Daniel W Lin
Urologic Oncology|November 23, 2005
Editorial comment on "Treatment of nonretroperitoneal residual germ cell tumor masses"Daniel W Lin, Paul H Lange
Nature Reviews. Urology|December 4, 2009
Genetics: Prostate cancer risk stratification by genotype and PSAJonathan L Wright, Daniel W Lin
JAMA Oncology|November 5, 2016
Avoiding Undertreatment of Aggressive Prostate Cancer by Early Use of ChemotherapyEvan Y Yu, Daniel W Lin
European Urology|April 15, 2020
Active Surveillance for Prostate Cancer: A 2020 VisionMatthew R Cooperberg, Daniel W Lin
Urologic Oncology|July 14, 2007
Trends in renal cancer surgery and patient provider characteristics associated with partial nephrectomy in the United StatesMichael P Porter, Daniel W Lin
JAMA Oncology|November 25, 2020
Prognostic Genomic Biomarkers in Patients With Localized Prostate Cancer: Is Rising Utilization Justified by Evidence?Daniel W Lin, Peter S Nelson
Translational Andrology and Urology|August 25, 2021
Preface to "Current and Future Topics on Prostate Cancer"Badrinath R Konety, Daniel W Lin
Pageof 29